Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

被引：435

作者：

Kuo, Phillip H.

Kanal, Emanuel

Abu-Alfa, Ali K.

Cowper, Shawn E.

机构：

[1] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA

[2] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06520 USA

[3] Yale Univ, Sch Med, Dept Dermatol & Pathol, New Haven, CT 06520 USA

[4] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA USA

来源：

RADIOLOGY | 2007年 / 242卷 / 03期

关键词：

D O I：

10.1148/radiol.2423061640

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease. © RSNA, 2007.

引用

页码：647 / 649

页数：3

共 12 条

[1]

BOYD AS, IN PRESS J AM ACAD D

[2] Nephrogenic systemic fibrosis: The nosological and conceptual evolution of nephrogenic fibrosing dermopathy [J].